Begin main content

Reports

We found 4974 result(s)

Atomoxetine hydrochloride (Strattera)

Last Updated: September 25, 2006
Result type: Reports
Product Line: Common Drug Review
Generic Name: Atomoxetine hydrochloride
Indications: Attention deficit hyperactivity disorder

  • Brand Name: Strattera
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: S0085
  • Project Status: Complete
  • Submission Type: RequestForAdvice

Ramipril/hydrochlorothiazide (Altace HCT)

Last Updated: March 26, 2007
Result type: Reports
Product Line: Common Drug Review
Generic Name: Ramipril/hydrochlorothiazide
Indications: Hypertension

  • Brand Name: Altace HCT
  • Manufacturer: Sanofi-Aventis Canada Inc.
  • Project Number: S0095
  • Project Status: Complete
  • Submission Type: Resubmission

Sitaxsentan sodium (Thelin)

Last Updated: June 22, 2007
Result type: Reports
Product Line: Common Drug Review
Generic Name: Sitaxsentan sodium
Indications: Pulmonary arterial hypertension (WHO class II and III)

  • Brand Name: Thelin
  • Manufacturer: Encysive Canada Inc.
  • Project Number: S0099
  • Project Status: Complete
  • Submission Type: New

Idursulfase (Elaprase)

Last Updated: July 13, 2007
Result type: Reports
Product Line: Common Drug Review
Generic Name: Idursulfase
Indications: Mucopolysarccharidosis II (MPS II), Hunter Syndrome

  • Brand Name: Elaprase
  • Manufacturer: Shire Human Genetic Therapies, Inc.
  • Project Number: S0104
  • Project Status: Complete
  • Submission Type: New

Mixed amphetamine salts (Adderall XR)

Last Updated: November 29, 2007
Result type: Reports
Product Line: Common Drug Review
Generic Name: Mixed amphetamine salts
Indications: Attention deficit hyperactivity disorder, Adult

  • Brand Name: Adderall XR
  • Manufacturer: Shire Canada Inc.
  • Project Number: S0116
  • Project Status: Complete
  • Submission Type: NewIndication

Duloxetine hydrochloride (Cymbalta)

Last Updated: February 8, 2008
Result type: Reports
Product Line: Common Drug Review
Generic Name: Duloxetine hydrochloride
Indications: Pain, Neuropathic, Diabetic

  • Brand Name: Cymbalta
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: S0126
  • Project Status: Complete
  • Submission Type: New

Tags

Diabetes

Adalimumab (Humira)

Last Updated: April 15, 2008
Result type: Reports
Product Line: Common Drug Review
Generic Name: Adalimumab
Indications: Psoriasis

  • Brand Name: Humira
  • Manufacturer: Abbott Laboratories, Limited
  • Project Number: S0130
  • Project Status: Complete
  • Submission Type: NewIndication

Sitaxsentan sodium (Thelin)

Last Updated: May 5, 2008
Result type: Reports
Product Line: Common Drug Review
Generic Name: Sitaxsentan sodium
Indications: Pulmonary arterial hypertension (WHO class II and III)

  • Brand Name: Thelin
  • Manufacturer: Encysive Canada Inc.
  • Project Number: S0132
  • Project Status: Complete
  • Submission Type: Resubmission

Dabigatran etexilate (Pradaxa)

Last Updated: July 8, 2008
Result type: Reports
Product Line: Common Drug Review
Generic Name: Dabigatran etexilate
Indications: Thromboembolism (venous), prevention

  • Brand Name: Pradaxa
  • Manufacturer: Boehringer Ingelheim (Canada) Ltd.
  • Project Number: S0140
  • Project Status: Complete
  • Submission Type: New